Cargando…

Colorectal cancer mortality 10 years after a single round of guaiac faecal occult blood test (gFOBT) screening: experiences from a Danish screening cohort

BACKGROUND: In Denmark, colorectal cancer (CRC) is the third most frequent cancer. Randomised trials have shown that guaiac faecal occult blood test (gFOBT) screening can reduce CRC mortality, but a recent large randomised study from Finland did not find any effect. A feasibility study was carried o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bjerrum, Andreas, Andersen, Ole, Fischer, Anders, Lindebjerg, Jan, Lynge, Elsebeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Colorectal Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5174813/ https://www.ncbi.nlm.nih.gov/pubmed/28074150 http://dx.doi.org/10.1136/bmjgast-2016-000120

Ejemplares similares

Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening
por: Liedenbaum, M H, et al.
Publicado: (2009)

Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening.
por: Castiglione, G., et al.
Publicado: (1992)

Directly Mailing gFOBT Kits to Previous Responders Being Recalled for Colorectal Cancer Screening Increases Participation
por: Tinmouth, Jill, et al.
Publicado: (2020)

Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening Pilot
por: Saw, Kai Sheng, et al.
Publicado: (2023)

Effect of rehydration on guaiac-based faecal occult blood testing in colorectal cancer screening.
por: Castiglione, G., et al.
Publicado: (1993)

Guaiac based faecal occult blood testing for colorectal cancer screening: an obsolete strategy?
por: Young, Graeme P, et al.
Publicado: (2012)

Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme
por: Kearns, B, et al.
Publicado: (2014)

Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
por: Castiglione, G., et al.
Publicado: (1996)

Benefit‐to‐harm ratio of the Danish breast cancer screening programme
por: Beau, Anna‐Belle, et al.
Publicado: (2017)

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels
por: Hol, L, et al.
Publicado: (2009)

Preservation of bacterial DNA in 10-year-old guaiac FOBT cards and FIT tubes
por: Couto Furtado Albuquerque, Matheus, et al.
Publicado: (2017)

Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK
por: Damery, Sarah, et al.
Publicado: (2010)

Socioeconomic inequalities in interval colorectal cancer are explained by differences in faecal haemoglobin concentration and age: a register-based cohort study
por: Deding, Ulrik, et al.
Publicado: (2023)

Use of CT colonography in the English Bowel Cancer Screening Programme
por: Plumb, Andrew A, et al.
Publicado: (2014)

Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia–Brussels colorectal cancer screening programme
por: Guo, Feng, et al.
Publicado: (2020)

Piloting the Impact of Three Interventions on Guaiac Faecal Occult Blood Test Uptake within the NHS Bowel Cancer Screening Programme
por: White, Becky, et al.
Publicado: (2015)

Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust
por: Chambers, Julie A., et al.
Publicado: (2016)

Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
por: Emmanuel, Anton, et al.
Publicado: (2016)

Risk of a post-colonoscopy colorectal cancer in patients with type 2 diabetes: a Danish population-based cohort study
por: Troelsen, Frederikke Schønfeldt, et al.
Publicado: (2021)

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy
por: Sharp, L, et al.
Publicado: (2012)

Correction: Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia–Brussels colorectal cancer screening programme
por: Guo, Feng, et al.
Publicado: (2021)

Use of hospital resources in the Finnish colorectal cancer screening programme: a randomised health services study
por: Mäklin, Suvi, et al.
Publicado: (2015)

Faecal immunochemical testing (FIT) in symptomatic patients: what are we missing?
por: Farrugia, Alexia, et al.
Publicado: (2019)

Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold
por: Young, Graeme P, et al.
Publicado: (2020)

Nimble Approach: fast, adapting, calculating and ethically mindful approach to managing colorectal cancer screening programmes during a pandemic
por: Baxter, Nancy N, et al.
Publicado: (2022)

Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England
por: Murphy, Jacqueline, et al.
Publicado: (2017)

Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study)
por: Olson, Janet E, et al.
Publicado: (2020)

Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
por: Dhaliwal, A, et al.
Publicado: (2015)

Identifying the need for a UK colorectal cancer screening programme for patients with cystic fibrosis (CF): 10-year retrospective review of colonoscopy and colorectal cancer outcomes at a single CF centre
por: Sapru, Karuna, et al.
Publicado: (2023)

Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme
por: Ciatto, S, et al.
Publicado: (2007)

Physician‐office vs home uptake of colorectal cancer screening using FOBT/FIT among screening‐eligible US adults
por: Chido‐Amajuoyi, Onyema Greg, et al.
Publicado: (2019)

Screening for colorectal cancer with immunological FOBT
por: Ottó, S, et al.
Publicado: (2004)

Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location
por: Guittet, L, et al.
Publicado: (2009)

Mammographic Density and Screening Sensitivity, Breast Cancer Incidence and Associated Risk Factors in Danish Breast Cancer Screening
por: Lynge, Elsebeth, et al.
Publicado: (2019)

Impact of chronic diseases on effect of breast cancer screening
por: Beau, Anna‐Belle, et al.
Publicado: (2020)

Reply: Screening for colorectal cancer with immunological FOBT
por: Saito, Hiroshi, et al.
Publicado: (2004)

Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities
por: Syed Soffian, Sharifah Saffinas, et al.
Publicado: (2021)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells
por: Campregher, C, et al.
Publicado: (2008)

Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition
por: Fujisawa, T, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_suota2f46qtiuineck69o2fl2g